Vascular permeability alterations induced by arsenic

被引:35
作者
Chen, SC
Tsai, MH
Wang, HJ
Yu, HS
Chang, LW
机构
[1] Natl Hlth Res Inst, Div Environm Hlth & Occupat Med, Kaohsiung 807, Taiwan
[2] Kaohsiung Med Univ, Dept Anat, Kaohsiung, Taiwan
[3] Natl Taiwan Univ, Dept Dermatol, Taipei, Taiwan
关键词
arsenic; arsenic toxicity; vascular injury; vascular permeability;
D O I
10.1191/0960327104ht407oa
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
The impact of arsenic on the integrity of blood vessels in vivo via in situ exposure (local injection) of arsenic was investigated. Vascular permeability changes were evaluated by means of the Evans blue assay and the India ink tracer techniques. Rats were intravenously injected with Evans blue followed by intradermal injections of various doses of sodium arsenite on the back skins of the animals. Evans blue at different time points was extracted and assayed as indices of vascular leakage. Skin at various time point injection sites was sampled for arsenic measurement via graphite furnace atomic absorption spectroscopy. Our time course study with Evans blue technique demonstrated a biphasic pattern of vascular permeability change: an early phase of permeability reduction and a later phase of permeability promotion at all dose levels tested. The India ink tracer technique also demonstrated a time-correlated increase in vascular labelling in the tissues examined, signifying an increase in vascular leakage with time. Moreover, we found that despite an early increase in tissue arsenic content at time of injection, tissue arsenic declined rapidly and returned to near control levels after 30-60 min. Thus, an inverse correlation between tissue arsenic content and the extent of vascular permeability was apparent. This study provides the first demonstration that in situ exposure to arsenic will produce vascular dysfunction (vascular leakage) in vivo.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 26 条
[1]  
[Anonymous], 1997, ARSENIC EXPOSURE HLT
[2]   Structural alterations in the rat kidney after acute arsine exposure [J].
Ayala-Fierro, F ;
Baldwin, AL ;
Wilson, LM ;
Valeski, JE ;
Carter, DE .
LABORATORY INVESTIGATION, 2000, 80 (01) :87-97
[3]  
Baluk P, 1998, AM J PATHOL, V152, P1463
[4]   Arsenic induces oxidant stress and NF-kappa B activation in cultured aortic endothelial cells [J].
Barchowsky, A ;
Dudek, EJ ;
Treadwell, MD ;
Wetterharn, KE .
FREE RADICAL BIOLOGY AND MEDICINE, 1996, 21 (06) :783-790
[5]   ARSENIC INGESTION AND INTERNAL CANCERS - A REVIEW [J].
BATES, MN ;
SMITH, AH ;
HOPENHAYNRICH, C .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1992, 135 (05) :462-476
[6]   Clinical management of women with genomic BRCA1 and BRCA2 mutations [J].
Chang, J ;
Elledge, RM .
BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (02) :101-113
[7]   Inorganic arsenic: A need and an opportunity to improve risk assessment [J].
Chappell, WR ;
Beck, BD ;
Brown, KG ;
Chaney, R ;
Cothern, CR ;
Irgolic, KJ ;
North, DW ;
Thornton, I ;
Tsongas, TA .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1997, 105 (10) :1060-1067
[8]  
CHAPPELL WR, 1999, INT C ARS EXP HLTH E
[9]   CANCER POTENTIAL IN LIVER, LUNG, BLADDER AND KIDNEY DUE TO INGESTED INORGANIC ARSENIC IN DRINKING-WATER [J].
CHEN, CJ ;
CHEN, CW ;
WU, MM ;
KUO, TL .
BRITISH JOURNAL OF CANCER, 1992, 66 (05) :888-892
[10]  
CHEN CJ, 1990, CANCER RES, V50, P5470